The country has approved Sinovac Biotech’s Covid-19 vaccine for use in the elderly, a letter from the food and drug agency shows, potentially changing the country’s strategy which has prioritised its working population first.
That strategy was partially due to limited data on the vaccine’s safety for the elderly, authorities have said.
The Food and Drug Monitoring Agency (BPOM) said in a letter seen that it had authorised the use of Sinovac’s CoronaVac for the elderly “taking into account the emergency situation of the Covid-19 pandemic and the limited information on the benefits and safety of that vaccine”.
It was sent to Sinovac’s Indonesian partner, state-owned Bio Farma.
Wiku Adisasmito, spokesman for the country’s Covid-19 task force, confirmed the letter authenticity.
Bio Farma confirmed receiving the letter, though did not provide further details. — Reuters